Visit cardinalhealth.com for more information about Cardinal Health »

alt
Americas
Brazil flag
Brazil
English | Português
Canada flag
Canada
English
Puerto Rico flag
Puerto Rico
English
United States flag
United States
English
Europe, Middle East & Africa (EMEA)
Germany flag
Germany
Deutsch
Spain flag
Spain
Espanol
Europe, Middle East & Africa flag
Europe, Middle East & Africa
English
Asia-Pacific
Australia flag
Australia
English
China flag
China
中文
Japan flag
Japan
English | 日本語
Korea flag
Korea
English

News and Media

Latest News Release
Cardinal Health announces two strategic additions to its portfolio
11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
05/07/2024

DUBLIN, Ohio, May 7, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2024 to shareholders of record at the close of business on July 1, 2024.

About Cardinal Health 
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts
Media: Erich Timmerman, erich.timmerman@cardinalhealth.com and 614.757.8231
Investors: Matt Sims, Matt.Sims@cardinalhealth.com and 614.553.3661

SOURCE Cardinal Health

More Company News
Cardinal Health announces routine actinium-225 production from its Center for Theranostics Advancement
12/20/2024

Cardinal Health poised to become the first company to offer cGMP-compliant material at commercial scale by year end DUBLIN, Ohio, Dec. 20, 2024 – Cardinal Health (NYSE: CAH) today announced the...

Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
12/19/2024

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2025 on January 30, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health completes acquisition of Integrated Oncology Network
12/03/2024

ION accelerates development of Navista, integrating more than 100 providers at more than 50 community-based sites across 10 states into oncology practice alliance. DUBLIN, Ohio, Dec. 3, 2024 –...

Cardinal Health launches Kendall SCD SmartFlow™ Compression System
11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

View all company news »